Publications

  1. Zulfiqar M, Sugi M, Venkatesh SK, Loh JT, Ludwig DR, Ballard DH, Jayasekera C, Pannala R, Aqel B, Yano M. Imaging of Ischemic Cholangiopathy Following Donation after Circulatory Death Liver Transplant. Radiographics. 2024 Nov; 44 (11):e240031
    View PubMed
  2. Das I, Mathur AK, Aqel B, Harnois D, Mao S, Taner CB, Croome KP. " To sleep-perchance to dream ": Daytime surgery start times for liver transplantation with ex situ normothermic machine perfusion. Liver Transpl 2024 Jul 1; 30 (7):763-767 Epub 2024 Feb 09
    View PubMed
  3. Liu MC, Lizaola-Mayo B, Jayasekera CR, Mathur AK, Katariya N, Aqel B, Byrne TJ, Chascsa DMH. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant. J Gastrointest Cancer. 2024 Jun; 55 (2):969-974 Epub 2024 Mar 14
    View PubMed
  4. Rolak SC, Yetmar ZA, Lahr BD, Beam E, Razi S, Watt K, Yang L, Aqel BA, Mahmood M. Risk Factors for Surgical-site Infections After Liver Transplant: Does Perioperative Antibiotic Regimen Matter? Transplantation. 2024 May 1; 108 (5):1179-1188 Epub 2023 Dec 04
    View PubMed
  5. Aqel BA. Liver transplant in patients with metastatic colorectal cancer. Clin Adv Hematol Oncol 2024 May; 22 (4):183-184
    View PubMed
  6. Busebee B, Myhre L, Mara K, Aqel B, Taner T, Watt KD. De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis. Clin Transplant. 2024 Feb; 38(2):e15263.
    View PubMed
  7. McCain JD, Dickson RC, Cai J, Zhang N, Pungpapong S, Aqel BA, Chascsa DMH. Hepatitis B reactivation after solid organ transplantation: A single-center experience. Journal of Liver Transplantation. 2024; 15:100227
  8. Jadlowiec CC, Brooks A, Pont K, Macdonough E, Buckner Petty S, Valenti K, Lizaola-Mayo B, Frasco P, Aqel B, Mathur AK, Moss A, Reddy KS. Liver transplant outcomes using late allocation grafts. Liver Transpl. 2023 Dec 1; 29 (12):1323-1329 Epub 2023 July 12
    View PubMed
  9. Ruch B, Kumm K, Kirk WV, Geraghty PJ, Harbell JW, Aqel BA, Reddy KS, Katariya NN, Mathur AK. P2.3: Rapid Maastricht type 3 donors and normothermic perfusion: Relieving time constraints in non-renal organ recovery. Transplantation. 2023 Oct 1; 107 (10S1):82 Epub 2023 Oct 16
    View PubMed
  10. Egbert LK, Ohara SY, Das D, Brooks A, Mahdi G, Aqel B, Buckner Petty SA, Mathur AK, Moss A, Reddy KS, Jadlowiec CC. Expanding Liver Transplant Opportunities in Older Patients With Nonconventional Grafts. J Surg Res. 2023 Aug; 288:140-147. Epub 2023 Mar 24.
    View PubMed
  11. Jayasekera CR, Barnhill M, Chascsa DM, Aqel B, Carey EJ, Vargas HE. Fenofibrate Improves Outcomes in Ischemic Cholangiopathy After Liver Transplantation. Gastroenterology 2023 Jun; 164 (7):1321-1323.e2 Epub 2023 Mar 06
    View PubMed
  12. Ohara S, Lizaola-Mayo B, Macdonough E, Morgan P, Das D, Egbert L, Brooks A, Mathur AK, Aqel B, Reddy KS, Jadlowiec CC. Reassessing Geographic, Logistical, and Cold Ischemia Cutoffs in Liver Transplantation. Prog Transplant. 2023 Jun; 33(2):168-174. Epub 2023 Apr 03.
    View PubMed
  13. Kohli DR, Aqel BA, Segaran NL, Harrison ME, Fukami N, Faigel DO, Moss A, Mathur A, Hewitt W, Katariya N, Pannala R. Outcomes of endoscopic retrograde cholangiography and percutaneous transhepatic biliary drainage in liver transplant recipients with a Roux-en-Y biliary-enteric anastomosis. Ann Hepatobiliary Pancreat Surg. 2023 Feb 28; 27(1):49-55. Epub 2022 Oct 17.
    View PubMed
  14. Frasco PE, Mathur AK, Chang YH, Alvord JM, Poterack KA, Khurmi N, Bauer I, Aqel B. Days alive and out of hospital after liver transplant: comparing a patient-centered outcome between recipients of grafts from donation after circulatory and brain deaths. Am J Transplant. 2023 Jan; 23 (1):55-63 Epub 2023 Jan 11
    View PubMed
  15. Jadlowiec CC, Macdonough E, Pont K, Valenti K, Lizaola-Mayo B, Brooks A, Das D, Heilman R, Mathur AK, Hewitt W, Moss A, Aqel B, Reddy KS. Donation after circulatory death transplant outcomes using livers recovered by local surgeons. Liver Transpl. 2022 Nov; 28(11):1726-1734. Epub 2022 Apr 25.
    View PubMed
  16. Mercado LA, Bhangu HK, Calderon E, Mathur AK, Aqel B, Musto KR, Watt KD, Rosen CB, Bolan C, LeGout JD, Taner CB, Harnois DM, Croome KP. DCD Liver Grafts Can Safely Be Used for Recipients With Grade I-II Portal Vein Thrombosis: A Multicenter Analysis. Transplant Direct. 2022 Nov; 8 (11):e1392 Epub 2022 Oct 07
    View PubMed
  17. Pai RK, Jairath V, Hogan M, Zou G, Adeyi OA, Anstee QM, Aqel BA, Behling C, Carey EJ, Clouston AD, Corey K, Feagan BG, Kleiner DE, Ma C, McFarlane SC, Noureddin M, Ratziu V, Valasek MA, Younossi ZM, Harrison SA, Loomba R. Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology. 2022 Oct; 76 (4):1150-1163 Epub 2022 Apr 06
    View PubMed
  18. Chesdachai S, Udompap P, Yetmar ZA, Watt KD, Aqel BA, Yang L, Beam E. Infectious complications in acute graft-versus-host disease after liver transplantation. Transpl Infect Dis. 2022 Aug; 24 (4):e13843 Epub 2022 June 01
    View PubMed
  19. Ohara S, Macdonough E, Egbert L, Brooks A, Lizaola-Mayo B, Mathur AK, Aqel B, Reddy KS, Jadlowiec CC. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors. Medicina (Kaunas). 2022 Jun 17; 58(6).
    View PubMed
  20. Croome KP, Mathur AK, Aqel B, Yang L, Taner T, Heimbach JK, Rosen CB, Paz-Fumagalli R, Taner CB. Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort. Transplantation. 2022 Jun 1; 106 (6):1206-1214 Epub 2022 Aug 30
    View PubMed
  21. Zaver HB, Koop AH, Aqel BA, Palmer WC. Hereditary hemochromatosis and liver transplantation: A survey of symptoms, lifestyle, and physician counseling pre- and post-transplant. Clin Res Hepatol Gastroenterol. 2022 May; 46 (5):101898 Epub 2022 Feb 27
    View PubMed
  22. Katariya NN, Lizaola-Mayo BC, Chascsa DM, Giorgakis E, Aqel BA, Moss AA, Uson Junior PLS, Borad MJ, Mathur AK. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation. Cancers (Basel). 2022 Apr 19; 14 (9)
    View PubMed
  23. Jayasekera CR, Vikram HR, Rifat Z, Wagler J, Okubo K, Braaksma BR, Harbell JW, Jadlowiec CC, Katariya NN, Mathur AK, Moss A, Reddy KS, Singer A, Orenstein R, Saling CF, Seville MT, Mour GK, Vargas HE, Byrne TJ, Hewitt WR Jr, Aqel BA. Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience. Transplant Direct. 2022 Feb; 8 (2):e1286 Epub 2022 Jan 13
    View PubMed
  24. Laughlin BS, Petersen MM, Yu NY, Anderson JD, Rule WG, Borad MJ, Aqel BA, Sonbol MB, Mathur AK, Moss AA, Bekaii-Saab TS, Ahn DH, DeWees TA, Sio TT, Ashman JB. Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, definitive, or liver transplant-based neoadjuvant chemoradiotherapy strategies: a single-center experience. J Gastrointest Oncol. 2022 Feb; 13 (1):288-297
    View PubMed
  25. Okubo K, Iqbal S, Lizaola-Mayo B, Aqel B, Graf EH, Banacloche JCG, Singer AL, Harbell JW. Liver Transplant in a Polymerase Chain Reaction-Positive COVID-19 Recipient: A Case Report. Transplant Proc. 2021 Oct; 53 (8):2490-2494 Epub 2021 July 29
    View PubMed
  26. Frasco PE, Aqel B, Alvord JM, Poterack KA, Bauer I, Mathur AK. Statin Therapy and the Incidence of Thromboembolism and Vascular Events Following Liver Transplantation. Liver Transpl. 2021 Oct; 27 (10):1432-1442 Epub 2021 June 30
    View PubMed
  27. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290
    View PubMed
  28. Brumfiel CM, Patel MH, Aqel B, Lehrer M, Patel SH, Seetharam M. Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma. JAAD Case Rep. 2021 Aug; 14:78-81 Epub 2021 June 04
    View PubMed
  29. Aqel B, Wijarnpreecha K, Pungpapong S, Taner CB, Reddy K, Leise M, Mi L, Dickson RC. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients. J Hepatol. 2021 Apr; 74 (4):873-880 Epub 2020 Nov 12
    View PubMed
  30. Naidu S, Alzubaidi S, Knuttinen G, Patel I, Fleck A, Sweeney J, Aqel B, Larsen B, Buras M, Golafshar M, Oklu R. Treatment of Hepatic Artery Stenosis in Liver Transplant Patients Using Drug-Eluting versus Bare-Metal Stents. J Clin Med. 2021 Jan 20; 10 (3)
    View PubMed
  31. Kohli DR, Pannala R, Crowell MD, Fukami N, Faigel DO, Aqel BA, Harrison ME. Interobserver Agreement for Classifying Post-liver Transplant Biliary Strictures in Donation After Circulatory Death Donors. Dig Dis Sci. 2021 Jan; 66 (1):231-237 Epub 2020 Mar 03
    View PubMed
  32. Tse CS, Yang JD, Mousa OY, Nelson KM, Pungpapong S, Keaveny A, Aqel BA, Vargas H, Dickson RC, Watt K, Gores GJ, Roberts LR, Leise MD. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C. Transplant Direct. 2021 Jan; 7(1):e635. Epub 2020 Dec 08.
    View PubMed
  33. Nunez-Nateras R, Reddy KS, Aqel BA, Heilman R, Morgan P, Mathur AK, Hewitt W, Heimbach J, Rosen C, Moss AA, Taner T, Jadlowiec CC. Simultaneous liver-kidney transplantation from donation after cardiac death donors: an updated perspective. Am J Transplant. 2020 Dec; 20 (12):3582-3589 Epub 2020 Sept 27
    View PubMed
  34. Croome KP, Mathur AK, Mao S, Aqel B, Piatt J, Senada P, Heimbach JK, Moss A, Rosen CB, Taner CB. Perioperative and long-term outcomes of utilizing donation after circulatory death liver grafts with macrosteatosis: A multicenter analysis. Am J Transplant. 2020 Sep; 20 (9):2449-2456 Epub 2020 Apr 15
    View PubMed
  35. Bersoux S, Mi L, Aqel BA, Dickson RC. Hepatitis C Testing and Liver Fibrosis Predictors in the Birth Cohort of a Primary Care Practice. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug; 4 (4):384-390 Epub 2020 July 15
    View PubMed
  36. Kohli DR, Harrison ME, Mujahed T, Fukami N, Faigel DO, Pannala R, Moss A, Aqel BA. Outcomes of endoscopic therapy in donation after cardiac death liver transplant biliary strictures. HPB (Oxford). 2020 Jul; 22 (7):979-986 Epub 2019 Oct 29
    View PubMed
  37. Jadlowiec C, Smith M, Neville M, Mao S, Abdelwahab D, Reddy K, Moss A, Aqel B, Taner T. Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts. J Clin Med. 2020 Mar 30; 9 (4)
    View PubMed
  38. Rosenfeld DM, Smith ML, Seamans DP, Giorgakis E, Gaitan BD, Khurmi N, Aqel BA, Reddy KS. Fatal diffuse pulmonary fat microemboli following reperfusion in liver transplantation with the use of marginal steatotic allografts. Am J Transplant. 2019 Sep; 19 (9):2640-2645 Epub 2019 May 21
    View PubMed
  39. Mathur AK, Stemper-Bartkus C, Engholdt K, Thorp A, Dosmann M, Khamash H, Reddy KS, Aqel B, Moss A, Chakkera H, Steidley DE, Pajaro O, Shah S, Oakley EJ, Douglas D. Identifying Patterns of Adverse Events of Solid Organ Transplantation Through Departmental Case Reviews. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3 (3):335-343 Epub 2019 July 19
    View PubMed
  40. Kohli DR, Harrison ME, Adike AO, El Kurdi B, Fukami N, Faigel DO, Pannala R, Moss AA, Aqel BA. Predictors of Biliary Strictures After Liver Transplantation Among Recipients of DCD (Donation After Cardiac Death) Grafts. Dig Dis Sci. 2019 Jul; 64 (7):2024-2030 Epub 2019 Jan 02
    View PubMed
  41. DeLeon TT, Salomao MA, Aqel BA, Sonbol MB, Yokoda RT, Ali AH, Moss AA, Mathur AK, Chascsa DM, Rakela J, Bryce AH, Borad MJ. Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience. J Gastrointest Oncol. 2018 Dec; 9 (6):1054-1062
    View PubMed
  42. Palmer WC, Vishnu P, Sanchez W, Aqel B, Riegert-Johnson D, Seaman LAK, Bowman AW, Rivera CE. Diagnosis and Management of Genetic Iron Overload Disorders. J Gen Intern Med. 2018 Dec; 33 (12):2230-2236 Epub 2018 Sept 17
    View PubMed
  43. Snipelisky D, Shipman J, Olson N, Pellikka P, Aqel B, McCully R, Watt K. Low to Intermediate Dose Atropine Administration During Dobutamine Stress Echocardiography in the Pre-Liver Transplant Population. Prog Transplant. 2018 Dec; 28 (4):361-367 Epub 2018 Sept 16
    View PubMed
  44. Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Nidamanuri S, Rodriguez E, Franco D, Ryland K, Keaveny AP, Huskey JL, Smith M, Reddy KS, Taner CB, Vargas HE, Aqel BA. Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant. 2018 Oct; 18 (10):2559-2565 Epub 2018 June 08
    View PubMed
  45. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Sep - Oct; 17 (5):815-821
    View PubMed
  46. DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ. Novel immunotherapy strategies for hepatobiliary cancers. Immunotherapy. 2018 Sep; 10 (12):1077-1091
    View PubMed
  47. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Aug 24; 17 (5):815-821
    View PubMed
  48. Charlton M, Levitsky J, Aqel B, O'Grady J, Hemibach J, Rinella M, Heimbach J, Fung J, Ghabril M, Thomason R, Burra P, Little EC, Berenguer M, Shaked A, Trotter J, Roberts J, Rodriguez-Davalos M, Rela M, Pomfret E, Heyrend C, Gallegos-Orozco J, Saliba F. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018 May; 102 (5):727-743
    View PubMed
  49. DeLeon TT, Ahn DH, Bogenberger JM, Anastasiadis PZ, Arora M, Ramanathan RK, Aqel BA, Vasmatzis G, Truty MJ, Oklu R, Bekaii-Saab TS, Borad MJ. Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma. Future Oncol. 2018 Mar; 14 (6):553-566 Epub 2018 Feb 20
    View PubMed
  50. Dollard SC, Douglas D, Basavaraju SV, Schmid DS, Kuehnert M, Aqel B. Donor-derived Kaposi's sarcoma in a liver-kidney transplant recipient. Am J Transplant. 2018 Feb; 18 (2):510-513 Epub 2017 Oct 25
    View PubMed
  51. Perez ST, Arring NM, Vargas HE, Corbett BM, Ehler S, Beck GL, Temkit M, Aqel BA, Rakela J. Improving hepatitis vaccination series completion in patients awaiting liver transplantation. Journal for Nurse Practitioners. 2017; 13 (9):e441-4
  52. Adike A, Al-Qaisi M, Baffy NJ, Kosiorek H, Pannala R, Aqel B, Faigel DO, Harrison ME, Harrison ME. International Normalized Ratio Does Not Predict Gastrointestinal Bleeding After Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis. Gastroenterology Res. 2017 Jun; 10 (3):177-181 Epub 2017 June 30
    View PubMed
  53. Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ, Sidey J, Shi H, Aqel BA, McClain CJ, Prough RA. Nuclear receptors and nonalcoholic fatty liver disease. Biochim Biophys Acta. 2016 Sep; 1859 (9):1083-1099 Epub 2016 Mar 04
    View PubMed
  54. Mathur AK, Aqel B, Moss AA. Should quality of the liver transplant candidate evaluation be measured? Clin Liver Dis (Hoboken). 2016 Sep; 8 (3):64-67 Epub 2016 Oct 02
    View PubMed
  55. Kahn A, Reynolds JA, Chakkera HA, Aqel BA, Byrne TJ, Douglas DD, Moss AA, Vargas HE, Carey EJ. Prospective Analysis of Metabolic Parameters in the Detection of Diabetes and Metabolic Syndrome in Liver Transplant Recipients. Metab Syndr Relat Disord. 2016 Aug; 14 (6):305-10 Epub 2016 May 10
    View PubMed
  56. Kransdorf LN, Millstine D, Smith ML, Aqel BA. Hepatic glycogen deposition in a patient with anorexia nervosa and persistently abnormal transaminase levels. Clin Res Hepatol Gastroenterol. 2016 Apr; 40: (2)e15-8.
    View PubMed
  57. Aqel B, DiBaise JK. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Nutr Clin Pract. 2015 Dec; 30: (6)780-6.
    View PubMed
  58. Aqel B. New, novel agents for patients with refractory hepatic encephalopathy, liver disease. Digestive Diseases Interview. 2015 Oct.
  59. Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015 Oct; 62 (4):1004-12 Epub 2015 Aug 07
    View PubMed
  60. Pungpapong S, Aqel B, Leise M, Werner KT, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Vargas HE, Keaveny AP. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology. 2015 Jun; 61 (6):1880-6 Epub 2015 Apr 27
    View PubMed
  61. Aqel BA, Vargas HE. Hepatitis C virus infection in nonliver solid organ transplant candidates and recipients. Curr Opin Organ Transplant. 2015 Jun; 20 (3):259-66
    View PubMed
  62. Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015 Feb; 29(2):134-41. Epub 2015 Jan 09.
    View PubMed
  63. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging. 2014 Dec 02.
    View PubMed
  64. Corey RL, Whitaker MD, Crowell MD, Keddis MT, Aqel B, Balan V, Byrne T, Carey E, Douglas DD, Harrison ME, Vargas HE, Rakela J. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation. Clin Transplant. 2014 May; 28 (5):579-84 Epub 2014 Apr 21
    View PubMed
  65. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19 (7):690-700 Epub 2013 June 03
    View PubMed
  66. Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013 Jun; 58 (6):1776-80 Epub 2013 Jan 12
    View PubMed
  67. Hsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2013 Jan; 77 (1):47-54 Epub 2012 Oct 11
    View PubMed
  68. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. J Transplant. 2013; 2013:269096 Epub 2013 Sept 24
    View PubMed
  69. Byrne TJ, Parish JM, Somers V, Aqel BA, Rakela J. Evidence for liver injury in the setting of obstructive sleep apnea. Ann Hepatol. 2012 Mar-Apr; 11 (2):228-31
    View PubMed
  70. Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012; 2012:614781 Epub 2012 Jan 29
    View PubMed
  71. Hsieh TH, McCullough A, Aqel B. Gastric mucosal calcinosis. Gastrointest Endosc. 2011 Jun; 73(6):1282-3. Epub 2011 Mar 27.
    View PubMed
  72. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, Douglas DD. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010 Dec; 16 (12):1373-8
    View PubMed
  73. Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, Heilman RL, Rakela J, Mekeel K, Reddy K, Vargas HE. Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Transplantation. 2010 Aug 27; 90 (4):407-11
    View PubMed
  74. Hagedorn HJ, Rettmann NA, Dieperink EW, Durfee J, Aqel B. Antibody response to hepatitis B vaccine in substance use disorder patients. Drug Alcohol Depend. 2010 Feb 1; 107(1):39-43. Epub 2009 Sep 27.
    View PubMed
  75. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl. 2009 Dec; 15 (12):1872-81
    View PubMed
  76. Briet F, Aqel BA, Jeejeebhoy KN, Scolapio JS. A low pretransplant peripheral blood mononuclear cell complex I activity predicts metabolic disturbances and inability to regain fat free mass in cirrhotic patients undergoing liver transplantation. Nutr Res. 2009 Jan; 29(1):26-34.
    View PubMed
  77. Boetticher NC, Peine CJ, Kwo P, Abrams GA, Patel T, Aqel B, Boardman L, Gores GJ, Harmsen WS, McClain CJ, Kamath PS, Shah VH. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008 Dec; 135 (6):1953-60 Epub 2008 Sept 13
    View PubMed
  78. Aqel BA, Ho SB. Surveillance for hepatocellular carcinoma. Postgrad Med. 2006 Sep-Oct; 119(3):19-24.
    View PubMed
  79. Aqel BA, Scolapio JS, Dickson RC, Burton DD, Bouras EP. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol. 2005 Nov; 3 (11):1095-100
    View PubMed
  80. Aqel BA, Machicao V, Rosser B, Satyanarayana R, Harnois DM, Dickson RC. Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol. 2004 Oct; 38 (9):805-9
    View PubMed
  81. Machicao VI, Krishna M, Bonatti H, Aqel BA, Nguyen JH, Weigand SD, Rosser BG, Hughes C, Dickson RC. Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl. 2004 May; 10(5):599-606.
    View PubMed
  82. Aqel B, Scolapio J, Nguyen J, Krishna M, Raimondo M. Recurrent pancreatitis due to a cystic pancreatic tumor: a rare presentation of acinar cell carcinoma. JOP. 2004 May; 5(3):151-4.
    View PubMed
  83. Machicao VI, Bonatti H, Krishna M, Aqel BA, Lukens FJ, Nguyen JH, Rosser BG, Satyanarayana R, Grewal HP, Hewitt WR, Harnois DM, Crook JE, Steers JL, Dickson RC. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Transplantation. 2004 Jan 15; 77(1):84-92.
    View PubMed
  84. Aqel B, Bishop M, Krishna M, Cangemi J. Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature. Dig Dis Sci. 2003 Dec; 48 (12):2323-7
    View PubMed